Cross-Sector entity

Center for Biological Diversity

organization
8

Doug Burgum is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. pharma accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 9 original sources each.

2 verified stories tracked

Last mentioned: Jul 18, 2026

Entity pulse

Recent coverage · Center for Biological Diversity

2 stories
8 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Center for Biological Diversity

Doug Burgum is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. pharma accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 9 original sources each. Center for Biological Diversity appears in 2 tracked Cross-Sector stories from July 18, 2026.

Stories tracked
2
Sources per story
9

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Center for Biological Diversity. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Center for Biological Diversity 2

Climate regulation Neutral 8

50-Year ESA Safety Net Removed; Climate-Threatened Species Now at Greater Risk

The U.S. Interior Department is dismantling a 50-year-old blanket protection for threatened species under the Endangered Species Act, a move environmental groups say will accelerate extinctions as climate change intensifies habitat loss. The new rules require individualized species protection plans and allow economic considerations to override critical habitat designations, potentially benefiting fossil fuel and mining sectors.

9 sources
Biotech pharma Neutral 8

49-Year Species Rule Ends: Biotech’s Natural Drug Library Faces Extinction Risk

The U.S. Interior Department’s cancellation of automatic ESA protections for threatened species could accelerate biodiversity loss, directly threatening the natural sources of many pharmaceuticals. Bioprospecting and natural product R&D face heightened uncertainty as habitat destruction outpaces species discovery. The rule change adds regulatory complexity for biotech companies seeking access to rare organisms.

9 sources

Source: thepeterboroughexaminer.com · mendocinobeacon.com